Literature DB >> 27912036

Failure to Redose Antibiotic Prophylaxis in Long Surgery Increases Risk of Surgical Site Infection.

Nongyao Kasatpibal1,2, Joanne D Whitney2, E Patchen Dellinger3, Bala G Nair4, Kenneth C Pike5.   

Abstract

BACKGROUND: Antibiotic prophylaxis is a key component of the prevention of surgical site infection (SSI). Failure to manage antibiotic prophylaxis effectively may increase the risk of SSI. This study aimed to examine the effects of antibiotic prophylaxis on SSI risk.
METHODS: A retrospective cohort study was conducted among patients having general surgery between May 2012 and June 2015 at the University of Washington Medical Center. Peri-operative data extracted from hospital databases included patient and operation characteristics, intra-operative medication and fluid administration, and survival outcome. The effects of antibiotic prophylaxis and potential factors on SSI risk were estimated using multiple logistic regression and were expressed as risk ratios (RRs).
RESULTS: A total of 4,078 patients were eligible for analysis. Of these, 180 had an SSI. Mortality rates within and after 30 days were 0.8% and 0.3%, respectively. Improper antibiotic redosing increased the risk of SSI (RR 4.61; 95% confidence interval [CI] 1.33-15.91). Other risk factors were in-patient status (RR 4.05; 95% CI 1.69-9.66), smoking (RR 1.63; 95% CI 1.03-2.55), emergency surgery (RR 1.97; 95% CI 1.26-3.08), colectomy (RR 3.31; 95% CI 1.19-9.23), pancreatectomy (RR 4.52; 95% CI 1.53-13.39), proctectomy (RR 5.02; 95% CI 1.72-14.67), small bowel surgery (RR 6.16; 95% CI 2.13-17.79), intra-operative blood transfusion >500 mL (RR 2.76; 95% CI 1.45-5.26), and multiple procedures (RR 1.40; 95% CI 1.01-1.95).
CONCLUSIONS: These data demonstrate that failure to redose prophylactic antibiotic during long operations increases the risk of SSI. Strengthening a collaborative surgical quality improvement program may help to eradicate this risk.

Entities:  

Keywords:  antibiotic prophylaxis; surgical site infection

Mesh:

Substances:

Year:  2016        PMID: 27912036     DOI: 10.1089/sur.2016.164

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  6 in total

1.  Antimicrobial Prophylaxis Redosing Reduces Surgical Site Infection Risk in Prolonged Duration Surgery Irrespective of Its Timing.

Authors:  Daniela Bertschi; Walter P Weber; Jasmin Zeindler; Daniel Stekhoven; Robert Mechera; Lilian Salm; Marco Kralijevic; Savas D Soysal; Marco von Strauss; Edin Mujagic; Walter R Marti
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

Review 2.  Prevention of fracture-related infection: a multidisciplinary care package.

Authors:  Willem-Jan Metsemakers; Jolien Onsea; Emilie Neutjens; Ester Steffens; Annette Schuermans; Martin McNally; Stefaan Nijs
Journal:  Int Orthop       Date:  2017-08-22       Impact factor: 3.075

3.  Adherence to Perioperative Antibiotic Prophylaxis Recommendations and Its Impact on Postoperative Surgical Site Infections.

Authors:  Claudia Berrondo; Marco Carone; Cindy Katz; Avi Kenny
Journal:  Cureus       Date:  2022-06-11

4.  Protective effect of intraoperative re-dose of prophylactic antibiotics on surgical site infection in diabetic patients: a retrospective cohort study.

Authors:  Xu Zhang; Tan Li; Yan Li; Miao He; Ya-Qi Liu; Meng-Ying Wang; Shi-Jie Xin; Qun Zhao
Journal:  Ann Transl Med       Date:  2019-03

5.  Chitin Oligosaccharide (COS) Reduces Antibiotics Dose and Prevents Antibiotics-Caused Side Effects in Adolescent Idiopathic Scoliosis (AIS) Patients with Spinal Fusion Surgery.

Authors:  Yang Qu; Jinyu Xu; Haohan Zhou; Rongpeng Dong; Mingyang Kang; Jianwu Zhao
Journal:  Mar Drugs       Date:  2017-03-14       Impact factor: 5.118

6.  The efficacy of ampicillin compared with ceftriaxone on preventing cesarean surgical site infections: an observational prospective cohort study.

Authors:  Srisuda Assawapalanggool; Nongyao Kasatpibal; Supatra Sirichotiyakul; Rajin Arora; Watcharin Suntornlimsiri; Anucha Apisarnthanarak
Journal:  Antimicrob Resist Infect Control       Date:  2018-01-22       Impact factor: 4.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.